These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3320783)

  • 1. Oslo study: treatment of mild hypertension. A five-year controlled drug study.
    Helgeland A; Leren P
    Nephron; 1987; 47 Suppl 1():108-10. PubMed ID: 3320783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3.
    Holme I; Kjeldsen SE
    Eur J Intern Med; 2015 Mar; 26(2):123-6. PubMed ID: 25681139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary heart disease and treatment of hypertension. Some Oslo Study data.
    Leren P; Helgeland A
    Am J Med; 1986 Feb; 80(2A):3-6. PubMed ID: 2868657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.
    Helgeland A
    Am J Med; 1980 Nov; 69(5):725-32. PubMed ID: 7001898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oslo Hypertension Study.
    Leren P; Helgeland A
    Drugs; 1986; 31 Suppl 1():41-5. PubMed ID: 2873015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of antihypertensive therapy on quality of life: effect of hydrochlorothiazide.
    Williams GH; Croog SH; Levine S; Testa MA; Sudilovsky A
    J Hypertens Suppl; 1987 Feb; 5(1):S29-35. PubMed ID: 3553493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
    Brunner HR; Waeber B; Ferguson RK; Turini GA; Gavras H
    Cardiology; 1979; 64 Suppl 1():88-95. PubMed ID: 42489
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of an antihypertensive agent. Comparison of methyldopa and hydrochlorothiazide in combination and singly.
    McMahon FG
    JAMA; 1975 Jan; 231(2):155-8. PubMed ID: 1088916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study.
    Helgeland A; Leren P; Foss OP; Hjermann I; Holme I; Lund-Larsen PG
    Am J Med; 1984 May; 76(5):802-5. PubMed ID: 6720727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL-cholesterol in antihypertensive treatment. The Oslo Study.
    Helgeland A; Leren P; Enger SC; Hjermann I; Holme I
    Acta Med Scand Suppl; 1979; 625():131-4. PubMed ID: 219665
    [No Abstract]   [Full Text] [Related]  

  • 14. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antihypertensive therapy on left ventricular function and myocardial perfusion at rest and during exercise.
    Rosendorff C; Goodman C; Coull A
    J Hypertens Suppl; 1984 Dec; 2(2):S63-8. PubMed ID: 6100879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the ratio of plasma to intersitiial fluid volume during long-term antihypertensive therapy.
    Leth A; Ibsen H
    J Lab Clin Med; 1976 May; 87(5):781-91. PubMed ID: 1270888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study.
    Helgeland A; Hjermann I; Holme I; Leren P
    Am J Med; 1978 Jan; 64(1):34-8. PubMed ID: 623136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies in hypertension: mild hypertension, isolated systolic hypertension, and the choice of a step one drug.
    Cressman MD; Gifford RW
    Clin Cardiol; 1983 Jan; 6(1):1-10. PubMed ID: 6339130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of antihypertensive therapy on the quality of life.
    Croog SH; Levine S; Testa MA; Brown B; Bulpitt CJ; Jenkins CD; Klerman GL; Williams GH
    N Engl J Med; 1986 Jun; 314(26):1657-64. PubMed ID: 3520318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.